Pre-market hot trades in US stocks: Regeneron Pharma up 8.21% in pre-market, strategic cooperation boosts confidencePrice Alert·1 day ago, 04:42 AMREGN+0.63%
Here's What to Expect From Regeneron Pharmaceuticals’ Next Earnings ReportBarchart Option·2 days ago, 06:53 AMREGN+0.63%
Tessera Therapeutics Appoints Joseph Romanelli as President and Chief Executive Officer | MRK Stock NewsStockTitan·2 days ago, 04:00 AMREGN+0.63%
Regeneron Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To CompetitorsMarketWatch Automated·2 days ago, 03:43 PMREGN+0.63%
Regeneron Pharmaceuticals, Inc. (REGN) Faces Securities Class Action Amid Disclosures About Key Trial's Protocol and Ultimate Failure - HBSSPR Newswire·Jul 21 at 06:00 PMREGN+0.63%
REGN Breaking News: Regeneron Inc. Sued for Securities Fraud after Revealing Failed Phase III Clinical Trial Resulting in 10% Stock Drop – Investors Notified to Contact BFA LawMorningStar·Jul 21 at 03:14 PMREGN+0.63%
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $1,000.00Market Beat·Jul 21 at 09:18 AMREGN+0.63%
TLX: Q2 2026 revenue up 21% YoY to US $247M, with FY 2026 revenue expected to surpass US $1BQuartr·Jul 20 at 05:41 PMTLX-2.76%REGN+0.63%
Telix Q2 Revenue US$247M, Strong Momentum and Pipeline Progress | TLX Stock NewsStockTitan·Jul 20 at 10:31 AMTLX-2.76%REGN+0.63%
